In this study, we also observed lower levels of miR-16-5p in CD138+ plasma cells of MM patients compared to CD138+ plasma cells of sMM patients, indicating that not only the circulating but also the intracellular miR-16-5p levels decrease during MM progression. This evidence concerns the gene SDC1 and Miyoshi myopathy.